Case No.
|
Age (y)
|
Sex
|
Tumor size (cm)
|
Site
|
IA cycles
|
Arteriographic response
|
Histological response
|
Diagnosis date
|
OR typea
|
MSTS
|
FU (mo)
|
First relapse
|
Status
|
| 1 |
18 |
M |
8 |
Femur, distal |
3 |
<90% |
50% |
5/15/1987 |
1 |
100% |
166 |
|
CDF |
| 2 |
10 |
M |
>10 |
Humerus, proximal |
4 |
>90% |
95% |
11/20/1987 |
1 |
63% |
158 |
|
CDF |
| 3 |
20 |
F |
7 |
Tibia, proximal |
4 |
>90% |
>90% |
4/7/1988 |
1 |
60% |
145 |
|
CDF |
| 4 |
9 |
M |
<10 |
Humerus, proximal |
5 |
>90% |
>90% |
6/15/1988 |
1 |
73% |
158 |
|
CDF |
| 5 |
11 |
M |
<10 |
Femur, distal |
4 |
>90% |
95% |
6/29/1988 |
1 |
47% |
164 |
|
CDF |
| 6 |
15 |
M |
<10 |
Femur, distal |
5 |
>90% |
95% |
10/28/1988 |
3 |
NA |
115 |
|
DOO |
| 7 |
17 |
M |
10 |
Femur, distal |
4 |
>90% |
80% |
10/12/1989 |
1 |
23% |
127 |
|
CDF |
| 8 |
19 |
M |
18 |
Tibia, proximal |
4 |
>90% |
99% |
10/13/1989 |
1 |
83% |
141 |
|
CDF |
| 9 |
18 |
M |
>10 |
Femur, distal |
4 |
>90% |
>90% |
11/17/1989 |
1 |
83% |
134 |
|
CDF |
| 10 |
16 |
M |
>10 |
Fibula, proximal |
5 |
<90% |
95% |
1/15/1990 |
1 |
NA |
91 |
January 1994 |
DOD |
| 11 |
18 |
M |
<10 |
Tibia, proximal |
5 |
>90% |
95% |
4/4/1990 |
1 |
67% |
139 |
|
CDF |
| 12 |
19 |
M |
>10 |
Fibula, proximal |
4 |
>90% |
95% |
5/15/1990 |
1 |
100% |
128 |
|
CDF |
| 13 |
13 |
M |
>10 |
Femur, distal |
4 |
>90% |
95% |
8/24/1990 |
2 |
80% |
113 |
|
CDF |
| 14 |
13 |
M |
<10 |
Femur, distal |
4 |
>90% |
99% |
9/14/1990 |
1 |
40% |
134 |
|
CDF |
| 15 |
11 |
M |
<10 |
Humerus, proximal |
4 |
>90% |
95% |
12/3/1990 |
1 |
70% |
127 |
|
CDF |
| 16 |
18 |
F |
>10 |
Femur, distal |
4 |
>90% |
95% |
5/9/1991 |
1 |
90% |
44 |
|
CDF |
| 17 |
10 |
M |
12 |
Humerus, proximal |
4 |
>90% |
95% |
6/7/1991 |
1 |
70% |
120 |
October 1993 |
NED |
| 18 |
9 |
F |
>10 |
Femur, distal |
5 |
>90% |
99% |
7/10/1991 |
1 |
43% |
116 |
|
CDF |
| 19 |
16 |
M |
>10 |
Femur, distal |
4 |
<90% |
<90% |
10/1/1991 |
2 |
50% |
119 |
|
CDF |
| 20 |
15 |
M |
<10 |
Femur, distal |
3 |
<90% |
<90% |
2/13/1992 |
1 |
NA |
28 |
December 1992 |
DOD |
| 21 |
7 |
F |
<10 |
Femur, distal |
3 |
>90% |
>90% |
3/19/1992 |
2 |
63% |
102 |
|
CDF |
| 22 |
18 |
M |
<10 |
Ulna, mid |
4 |
>90% |
95% |
5/27/1992 |
1 |
100% |
111 |
|
CDF |
| 23 |
12 |
M |
<10 |
Femur, mid |
4 |
>90% |
99% |
9/18/1992 |
1 |
87% |
93 |
|
CDF |
| 24 |
16 |
F |
>10 |
Tibia, proximal |
4 |
>90% |
>90% |
10/2/1992 |
2 |
NA |
33 |
October 1994 |
DOD |
| 25 |
10 |
M |
<10 |
Femur, distal |
4 |
>90% |
98% |
12/9/1992 |
3 |
70% |
105 |
|
CDF |
| 26 |
8 |
M |
<10 |
Humerus, proximal |
4 |
>90% |
96% |
1/14/1993 |
1 |
77% |
104 |
|
CDF |
| 27 |
16 |
F |
12 |
Femur, distal |
3 |
>90% |
95% |
5/4/1993 |
1 |
30% |
98 |
|
CDF |
| 28 |
10 |
M |
11 |
Femur, distal |
3 |
>90% |
95% |
8/6/1993 |
1 |
90% |
101 |
|
CDF |
| 29 |
16 |
M |
15 |
Femur, distal |
4 |
>90% |
99% |
9/15/1993 |
1 |
47% |
95 |
|
CDF |
| 30 |
18 |
F |
11 |
Femur, distal |
4 |
>90% |
100% |
2/15/1994 |
1 |
37% |
97 |
|
CDF |
| 31 |
11 |
F |
9 |
Femur, distal |
5 |
>90% |
95% |
4/28/1994 |
1 |
100% |
88 |
|
CDF |
| 32 |
13 |
F |
10 |
Tibia, proximal |
3 |
>90% |
100% |
4/28/1995 |
1 |
93% |
76 |
October 1996 |
NED |
| 33 |
16 |
F |
10 |
Femur, distal |
4 |
>90% |
95% |
7/3/1995 |
1 |
90% |
77 |
|
CDF |
| 34 |
16 |
F |
9 |
Tibia, proximal |
4 |
>90% |
99% |
7/10/1995 |
1 |
90% |
71 |
|
CDF |
| 35 |
13 |
M |
>10 |
Femur, distal |
4 |
<90% |
99% |
3/12/1996 |
1 |
93% |
70 |
March 1997 |
NED |
| 36 |
20 |
M |
3 |
Femur, distal |
3 |
>90% |
99% |
10/23/1996 |
1 |
37% |
52 |
|
CDF |
| 37 |
18 |
M |
5 |
Femur, distal |
3 |
>90% |
95% |
2/7/1997 |
1 |
43% |
58 |
|
CDF |
| 38 |
15 |
F |
11 |
Femur, distal |
3 |
>90% |
95% |
6/5/1997 |
1 |
80% |
50 |
|
CDF |
| 39 |
17 |
M |
9 |
Tibia, mid |
3 |
>90% |
95% |
8/12/1997 |
1 |
97% |
48 |
|
CDF |
| 40 |
18 |
M |
15 |
Tibia, proximal |
4 |
<90% |
80% |
4/8/1998 |
1 |
80% |
36 |
October 2000 |
NED |
| 41 |
17 |
M |
7 |
Femur, distal |
4 |
>90% |
95% |
7/7/1998 |
1 |
83% |
38 |
|
CDF |
| 42 |
20 |
M |
8 |
Femur, distal |
4 |
>90% |
98% |
11/22/1998 |
1 |
47% |
27 |
|
CDF |
| 43 |
9 |
F |
11 |
Femur, distal |
4 |
<90% |
50% |
8/31/1999 |
3 |
43% |
24 |
|
CDF |
| 44 |
18 |
M |
19 |
Femur, mid |
4 |
>90% |
95% |
1/27/2000 |
1 |
20% |
22 |
|
CDF |
| 45 |
14 |
M |
12 |
Tibia, proximal |
4 |
>90% |
>90% |
4/21/2000 |
1 |
100% |
22 |
|
CDF |
| 46 |
15 |
F |
9 |
Femur, distal |
3 |
>90% |
99% |
5/30/2000 |
1 |
100% |
20 |
|
CDF |
| 47 |
7 |
M |
7 |
Femur, distal |
4 |
>90% |
95% |
6/8/2000 |
1 |
80% |
21 |
|
CDF |
|
| IA, intra-arterial; MSTS, Musculoskeletal Tumor Society Functional Evaluation; CDF, continuously disease free; NED, no evidence of disease; DOD, died of disease; DOO, died of other causes (i.e., motor vehicle accident); NA, not available. |
| a OR type = definitive surgery performed following neoadjuvant chemotherapy. 1, limb-salvage surgery; 2, primary amputation; 3, secondary amputation following complication after limb-salvage surgery. |
|